Francesco Ferraù

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

C. Gridelli, Federica Perrone, Ciro Gallo et al. · JNCI Journal of the National Cancer Institute · 2003 · 795 citations · Full text

Medicine, Oncology, Pharmacology +12

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

Francien H. van Nederveen, José Gaal, Judith Favier et al. · The Lancet Oncology · 2009 · 533 citations · Full text

Medicine, Oncology, Pathology +16

Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study

Paolo Maione, Francesco Perrone, Ciro Gallo et al. · Journal of Clinical Oncology · 2005 · 477 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

Ugo De Giorgi, Giuseppe Procopio, Diana Giannarelli et al. · Clinical Cancer Research · 2019 · 239 citations · Full text

Medicine, Immunology, Oncology +17